CD8A and neoplasm: In OVs treatment, CD8+ T cells are constantly exposed to tumor antigens and inflammatory signals which results in T cells exhaustion characterized by expression of multiple inhibitory molecules including PD-1, Tim3 and LAG3 (68, 69).